JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB300623

Anti-PINK1 antibody [MJF-R32-7]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

Be the first to review this product! Submit a review

|

(15 Publications)

Rabbit Recombinant Monoclonal PINK1 antibody. Suitable for WB and reacts with Human samples. Cited in 15 publications.

View Alternative Names

BRPK, PTEN-induced putative kinase protein 1, PINK1

3 Images
Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
  • WB

Lab

Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)

Western blot : Anti-PINK1 antibody [MJF-R32-7] (ab300623) staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta.

In Western blot, ab300623 was shown to bind specifically to PINK1. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with a high-sensitivity ECL substrate kit and imaged with 20 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

In Western blot, ab300623 was shown to bind specifically to PINK1. A band was observed at 63kDa in wild-type SH-SY5Y treated with CCCP cell lysates with no signal observed at this size in PINK1 knockout cell line (ab280876).

All lanes:

Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623)

Lane 1:

Wild-type SH-SY5Y treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 &mu;M, 24 h) cell lysate at 20 µg

Lane 2:

Wild-type SH-SY5Y control CCCP (0 &mu;M, 24 h) cell lysate at 20 µg

Lane 3:

PINK1 knockout SH-SY5Y (<a href='/en-us/products/cell-lines/human-pink1-knockout-sh-sy5y-cell-line-ab280876'>ab280876</a>) treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 uM, 24 h) cell lysate at 20 µg

Lane 4:

Western blot - Human PINK1 knockout SH-SY5Y cell line (<a href='/en-us/products/cell-lines/human-pink1-knockout-sh-sy5y-cell-line-ab280876'>ab280876</a>) at 20 µg

Lane 5:

Wild-type HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 &mu;M, 24 h) cell lysate at 20 µg

Lane 6:

PINK1 knockout HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 &mu;M, 24 h) cell lysate at 20 µg

Secondary

All lanes:

HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 63 kDa

Observed band size: 63 kDa

true

Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
  • WB

Supplier Data

Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)

Anti-PINK1 antibody [MJF-R32-7] (ab300623) staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. ab300623 was shown to bind specifically to PINK1. A band was observed at 60 kDa in wild-type HEK-293 cell lysates with no signal observed at this size in PINK1 knockout cell line ab266393 (knockout cell lysate ab257030). To generate this image, wild-type and PINK1 knockout HEK-293 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 4 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623) at 1/1000 dilution

Lane 1:

Wild-type HEK-293 Vehicle Control CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (0 µM, 24 h) cell lysate at 20 µg

Lane 2:

Wild-type HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 µM, 24 h) cell lysate at 20 µg

Lane 3:

PINK1 knockout HEK-293 Vehicle Control CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (0 µM, 24 h) cell lysate at 20 µg

Lanes 3 - 4:

Western blot - Human PINK1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pink1-knockout-hek-293t-cell-line-ab266393'>ab266393</a>)

Lane 4:

PINK1 knockout HEK-293 Treated CCCP, <a href='/en-us/products/biochemicals/cccp-mitochondrial-oxidative-phosphorylation-uncoupler-ab141229'>ab141229</a> (10 µM, 24 h) cell lysate at 20 µg

Secondary

All lanes:

HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 63 kDa

false

Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)
  • WB

Supplier Data

Western blot - Anti-PINK1 antibody [MJF-R32-7] (AB300623)

All lanes:

Western blot - Anti-PINK1 antibody [MJF-R32-7] (ab300623) at 1/1000 dilution

All lanes:

Rat testis tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

false

  • Carrier free

    Anti-PINK1 antibody [MJF-R32-7] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

MJF-R32-7

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody does not react in: IHC-P with human, mouse and rat; and in immunocytochemistry, flow cytometry and immunoprecipitation with human.
This antibody was mapped to AA 188-194 with some cross-reaction to AA 287-301.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The PTEN-induced kinase 1 (PINK1) is a serine/threonine-protein kinase with a molecular weight of approximately 63 kDa. It plays a significant role in mitochondrial quality control through its kinase activity. PINK1 gets expressed in various tissues with a high presence in the brain. The protein localizes to the outer membrane of damaged mitochondria to initiate mitophagy an important cellular process for clearing dysfunctional mitochondria.
Biological function summary

The PINK1 protein detects mitochondrial damage and recruits Parkin an E3 ubiquitin ligase to the damaged mitochondria. This interaction leads to the ubiquitylation of mitochondrial substrates and triggers their degradation. PINK1 Parkin and other proteins form a complex that facilitates the removal of damaged mitochondria through autophagy. This mechanism ensures cellular health and energy balance by maintaining a pool of functional mitochondria.

Pathways

PINK1 integrates into the mitochondrial quality control and mitophagy pathways. It has a fundamental role in the PINK1-Parkin pathway which is critical for maintaining mitochondrial integrity. In this pathway PINK1 phosphorylates both ubiquitin and Parkin enhancing Parkin’s E3 ligase activity. Another pathway that PINK1 participates in is the PTEN-induced kinase pathway where it regulates mitochondrial dynamics and homeostasis via cross-talk with other mitochondrial proteins such as DJ-1 and LRRK2.

PINK1 mutations are strongly associated with familial Parkinson’s disease attributing to its role in preserving neuronal function through mitochondrial regulation. Deficient PINK1 function leads to accumulation of damaged mitochondria contributing to neuronal cell death. Additionally PINK1 dysfunction is implicated in Alzheimer’s disease as impaired mitochondrial clearance is a contributing factor. Here the PINK1 interaction with other proteins like Parkin and DJ-1 highlights its importance in neurodegenerative disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase which acts as a sensor of mitochondrial damage and protects against mitochondrial dysfunction during cellular stress (PubMed : 40080546). It phosphorylates mitochondrial proteins to coordinate mitochondrial quality control mechanisms that remove and replace dysfunctional mitochondrial components (PubMed : 14607334, PubMed : 15087508, PubMed : 18443288, PubMed : 18957282, PubMed : 19229105, PubMed : 19966284, PubMed : 20404107, PubMed : 20547144, PubMed : 20798600, PubMed : 22396657, PubMed : 23620051, PubMed : 23754282, PubMed : 23933751, PubMed : 24660806, PubMed : 24751536, PubMed : 24784582, PubMed : 24896179, PubMed : 24898855, PubMed : 25527291, PubMed : 32484300). In healthy mitochondria, PINK1 is translocated across the mitochondrial outer membrane (MOM) via the translocase of the outer membrane (TOM) complex, and inserted into the mitochondrial inner membrane (MIM) via the translocase of the inner membrane (TIM23) complex where it is cleaved and released into the cytosol (PubMed : 40080546). Depending on the severity of mitochondrial damage, activity ranges from preventing apoptosis and stimulating mitochondrial biogenesis to eliminating severely damaged mitochondria via PINK1-PRKN-dependent mitophagy (PubMed : 14607334, PubMed : 15087508, PubMed : 18443288, PubMed : 19966284, PubMed : 20404107, PubMed : 20798600, PubMed : 22396657, PubMed : 23620051, PubMed : 23933751, PubMed : 24898855, PubMed : 32047033, PubMed : 32484300). When cellular stress results in irreversible mitochondrial damage, PINK1 accumulates at the outer mitochondrial membrane (OMM) where it phosphorylates pre-existing polyubiquitin chains at 'Ser-65', recruits PRKN from the cytosol to the OMM and activates PRKN by phosphorylation at 'Ser-65'; activated PRKN then ubiquitinates VDAC1 and other OMM proteins to initiate mitophagy (PubMed : 14607334, PubMed : 15087508, PubMed : 19966284, PubMed : 20404107, PubMed : 20798600, PubMed : 23754282, PubMed : 23933751, PubMed : 24660806, PubMed : 24751536, PubMed : 24784582, PubMed : 25474007, PubMed : 25527291, PubMed : 32047033, PubMed : 40080546). The PINK1-PRKN pathway also promotes fission of damaged mitochondria through phosphorylation and PRKN-dependent degradation of mitochondrial proteins involved in fission such as MFN2 (PubMed : 18443288, PubMed : 23620051, PubMed : 24898855). This prevents the refusion of unhealthy mitochondria with the mitochondrial network or initiates mitochondrial fragmentation facilitating their later engulfment by autophagosomes (PubMed : 18443288, PubMed : 23620051). Also promotes mitochondrial fission independently of PRKN and ATG7-mediated mitophagy, via the phosphorylation and activation of DNM1L (PubMed : 18443288, PubMed : 32484300). Regulates motility of damaged mitochondria by promoting the ubiquitination and subsequent degradation of MIRO1 and MIRO2; in motor neurons, this likely inhibits mitochondrial intracellular anterograde transport along the axons which probably increases the chance of the mitochondria undergoing mitophagy in the soma (PubMed : 22396657). Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity). Phosphorylates LETM1, positively regulating its mitochondrial calcium transport activity (PubMed : 29123128).
See full target information PINK1

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

Oncology research 33:2421-2434 PubMed40918465

2025

Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lingjuan Linghu,Hongying Zhou,Gang Zheng,Tao Yi

Histology and histopathology :18958 PubMed40654025

2025

SLMO2 inhibits apoptosis in ovarian cancer cells by modulating mitochondrial function via TRIAP1.

Applications

Unspecified application

Species

Unspecified reactive species

Yaqi Wang,Yuesong Wang,Zixuan Li,Tianmei Zhang

Pharmaceuticals (Basel, Switzerland) 17: PubMed39770569

2025

Inhibition of TFAM-Mediated Mitophagy by Oroxylin A Restored Sorafenib Sensitivity Under Hypoxia Conditions in HepG2 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shufan Ji,Xuefen Xu,Yujia Li,Sumin Sun,Qiuyu Fu,Yangling Qiu,Shuqi Wang,Siwei Xia,Feixia Wang,Feng Zhang,Ji Xuan,Shizhong Zheng

CNS neuroscience & therapeutics 30:e14878 PubMed39097923

2024

Honokiol relieves hippocampal neuronal damage in Alzheimer's disease by activating the SIRT3-mediated mitochondrial autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Haitao Li,Jinmei Sun,Yili Wu,Yishu Yang,Wei Zhang,Yuanruhua Tian

Experimental and therapeutic medicine 27:147 PubMed38476889

2024

Mitochondrial calcium uniporter promotes mitophagy by regulating the PINK1/Parkin pathway in caerulein‑treated pancreatic ductal epithelial cells  .

Applications

WB

Species

Human

Yu Lei,Hui-Ying Yang,Nuo Meng,Ying-Ying Qin,Meng-Tao Xu,Xue-Lian Xiang,Li Liu,Guo-Du Tang

Acta biochimica et biophysica Sinica 56:356-365 PubMed38419499

2024

HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells.

Applications

WB

Species

Human

Xinxin Kou,Xiaoxia Yang,Zheng Zhao,Lei Li

Journal of ethnopharmacology 325:117766 PubMed38266949

2024

Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway.

Applications

WB

Species

Rat

Keyan Jiao,Zili Lai,Qiaochu Cheng,Zhengyu Yang,Wenxin Liao,Yanhao Liao,Hongping Long,Ruiting Sun,Ting Lang,Le Shao,Changqing Deng,Yan She

Journal of ovarian research 17:12 PubMed38200521

2024

ErZhiTianGui Decoction alleviates age-related ovarian aging by regulating mitochondrial homeostasis and inhibiting ferroptosis.

Applications

WB

Species

Mouse

Jia Zhicheng,Li Yongqian,Wang Peixuan,Yang Kai,Shi Mengyu,Chen Wen,Liang Qihui,Guo Ying

Heliyon 10:e23077 PubMed38163129

2024

Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy.

Applications

WB

Species

Rat

Gang Luo,Li Chen,Mingtai Chen,Linshen Mao,Qihu Zeng,Yuan Zou,Jinyi Xue,Ping Liu,Qibiao Wu,Sijin Yang,Mengnan Liu

Acta biochimica Polonica 70:533-539 PubMed37672716

2023

Formononetin enhances the chemosensitivity of triple negative breast cancer via BTB domain and CNC homolog 1-mediated mitophagy pathways.

Applications

WB

Species

Human

Shan Li,Linlian Zhu,Yufeng He,Ting Sun
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com